2007. Metformin plus low glimepiride doses improve significantly HOMAir and HOMAbcell without hyperinsulinemia in patient with type 2 diabetes.

Metformin plus low glimepiride doses improve significantly HOMAir and HOMAbcell without hyperinsulinemia in patient with type 2 diabetes.
Autores: Bermúdez V, Cano C, Medina M, Souki A, Lemus M, Leal E, Seyfi H, Cano R, Ciszek A, Bermúdez F, Contreras F, Velasco M.
Referencia: American Journal of Therapeutics 2007; 14: 194-202.